ERBB2 and cancer: These results demonstrate the role of HER2 in breast tumor invasion and chemoresistance through up-regulating BCSC inside the tumor and the hypothesis that BCSCs are mostly responsible to tumor resistance and post-therapeutic cancer relapse.